Tolsulfamide Injection

This product is suitable for adult patients with central non-small cell lung cancer to relieve symptoms of severe airway obstruction (50% < tracheal
obstruction ≤ 75%; or unilateral main bronchial obstruction > 50%; or bilateral main bronchial obstruction, any unilateral obstruction
> 50%, and bilateral obstruction is not simultaneously > 75%).
For patients with extremely severe airway obstruction (tracheal obstruction > 75%, or bilateral main bronchial obstruction > 75%), the use of this product may aggravate airway obstruction due to reactions such as local airway edema, so it is not recommended to use this product alone. For details, see [Precautions].